SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-049852
Filing Date
2021-10-01
Accepted
2021-10-01 17:01:07
Documents
12
Period of Report
2021-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20210930.htm   iXBRL 8-K 30180
  Complete submission text file 0001564590-21-049852.txt   158008

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20210930.xsd EX-101.SCH 5709
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20210930_lab.xml EX-101.LAB 19326
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20210930_pre.xml EX-101.PRE 11504
5 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20210930_htm.xml XML 3547
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 211299753
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences